Allopurinol does not improve cardiovascular outcomes in ischemic heart disease patients
Can supplements or diet reduce symptoms of arthritis? Here’s what the evidence says
29 August 2022Long-term evolocumab therapy leads to further reductions in cardiovascular events
29 August 2022Allopurinol does not improve cardiovascular outcomes in ischemic heart disease patients
The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial infarction, nonfatal stroke or cardiovascular death in patients with ischemic heart disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.
